GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Allied Healthcare Products Inc (OTCPK:AHPIQ) » Definitions » Risk Assessment

Allied Healthcare Products (Allied Healthcare Products) Risk Assessment


View and export this data going back to 1992. Start your Free Trial

What is Allied Healthcare Products Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Allied Healthcare Products is: No Data: Cannot be evaluated.


Competitive Comparison of Allied Healthcare Products's Risk Assessment

For the Medical Devices subindustry, Allied Healthcare Products's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Allied Healthcare Products's Risk Assessment Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Allied Healthcare Products's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Allied Healthcare Products's Risk Assessment falls into.



Allied Healthcare Products  (OTCPK:AHPIQ) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.


Allied Healthcare Products Risk Assessment Related Terms

Thank you for viewing the detailed overview of Allied Healthcare Products's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.


Allied Healthcare Products (Allied Healthcare Products) Business Description

Traded in Other Exchanges
N/A
Address
1720 Sublette Avenue, Saint Louis, MO, USA, 63110
Allied Healthcare Products Inc manufactures a variety of respiratory products used in the healthcare industry in a wide range of hospital and alternate site settings, including sub-acute care facilities, home health care, and emergency medical care. The product line of the company includes respiratory anesthesia products, home respiratory care products, medical gas system construction products, medical gas system regulation devices, disposable oxygen, and specialty gas cylinders, portable suction equipment, trauma, and patient handling products, respiratory products, and others. The company markets its products under various brand names Timeter, Carbolime, Litholyme, Schuco, Chemetron, Oxequip, Lif-O-Gen, Gomco, and others.
Executives
John D Weil director, 10 percent owner 10 S. BROADWAY, SUITE 2000, ST LOUIS MO 63102
Susan M Deuser director 1720 SUBLETTE AVENUE, ST. LOUIS MO 63110
Kevin D Kroupa officer: Vice President of Operations 1720 SUBLETTE AVENUE, ST. LOUIS MO 63110
Earl R Refsland director, officer: President and CEO 1720 SUBLETT AVENUE, ST. LOUIS MO 63110
Joseph F Ondrus officer: Vice President of Operations 1720 SUBLETTE AVENUE, ST. LOUIS MO 63110
Andrew Riley officer: VP of Operations 1720 SUBLETTE AVE., ST. LOUIS MO 63110
William A Peck director 35 CROSBY DRIVE, BEDFORD MA 01730
Daniel C Dunn officer: VP - Finance and CFO 1720 SUBLETTE AVE, ST. LOUIS MO 63110
Eldon P Rosentrater officer: VP - Administration 1720 SUBLETTE AVE, ST. LOUIS MO 63110
Root Joseph Ernest Jr director HAYNES BEFFEL & WOLFELD LLP, 751 KELLY STREET, HALF MOON BAY CA 94019
Robert Bradley Harris officer: Vice President of Operations 15 RIVER RIDGE TRAIL, ORMOND BEACH FL 32174
Judy T Graves director 13317 WESTERMAN RD, ST LOUIS MO 63122
Hickey James B Jr director 4608 EDINA BLVD, EDINA MN 55424
Richard A Setzer officer: VICE PRESIDENT SALES & MKTG 1720 SUBLETTE AVENUE, ST. LOUIS MO 63110
Brent D Baird director 1350 ONE M&T PLAZA, BUFFALO NY 14203-2396